NEW YORK (GenomeWeb) – BioMérieux and Sysmex announced today that they will dissolve a nearly 10-year-old joint venture that aimed to bring BioMérieux's in vitro diagnostic products to the Japanese market.
No reason was given for the dissolution.
Get the full story
This story is free
for registered users
Registering provides access to this and other free content.
Register now.Already have an account?
Login Now.